Audrey Le Formal

684 total citations
18 papers, 422 citations indexed

About

Audrey Le Formal is a scholar working on Oncology, Pathology and Forensic Medicine and Reproductive Medicine. According to data from OpenAlex, Audrey Le Formal has authored 18 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 10 papers in Reproductive Medicine. Recurrent topics in Audrey Le Formal's work include Ovarian cancer diagnosis and treatment (10 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Genomics and Diagnostics (5 papers). Audrey Le Formal is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Genomics and Diagnostics (5 papers). Audrey Le Formal collaborates with scholars based in France, United Kingdom and United States. Audrey Le Formal's co-authors include Alexandra Léary, Catherine Genestie, Aurélie Auguste, Sébastien Gouy, Philippe Morice, Julien Adam, Soizick Mesnage, Enrica Bentivegna, Françoise Drusch and Judith Michels and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Audrey Le Formal

16 papers receiving 421 citations

Peers

Audrey Le Formal
Félix Blanc‐Durand France
S Liang United States
Joana Sederias Canada
Sherri Damare United States
Víctor Rodríguez-Freixinós Spain
Ahmed El‐Balat Germany
Keizo Tokumo Japan
Naoko Komura Japan
Anne‐Katrin Zimmermann Switzerland
Linn Woelber Germany
Félix Blanc‐Durand France
Audrey Le Formal
Citations per year, relative to Audrey Le Formal Audrey Le Formal (= 1×) peers Félix Blanc‐Durand

Countries citing papers authored by Audrey Le Formal

Since Specialization
Citations

This map shows the geographic impact of Audrey Le Formal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Le Formal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Le Formal more than expected).

Fields of papers citing papers by Audrey Le Formal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Le Formal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Le Formal. The network helps show where Audrey Le Formal may publish in the future.

Co-authorship network of co-authors of Audrey Le Formal

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Le Formal. A scholar is included among the top collaborators of Audrey Le Formal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Le Formal. Audrey Le Formal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Blanc‐Durand, Félix, Damien Vasseur, Audrey Le Formal, et al.. (2024). An evaluation of cell-free tumor DNA from 20 mL of peritoneal fluid for homologous recombination deficiency (HRD) testing in newly diagnosed ovarian cancer (OC).. Journal of Clinical Oncology. 42(16_suppl). 5577–5577. 1 indexed citations
2.
3.
Grau-Béjar, Juan Francisco, Qinghe Zeng, Catherine Genestie, et al.. (2024). Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer. Journal for ImmunoTherapy of Cancer. 12(7). e009143–e009143. 8 indexed citations
4.
Blanc‐Durand, Félix, Sophie Cotteret, Catherine Genestie, et al.. (2023). Clinical Relevance of BRCA1 Promoter Methylation Testing in Patients with Ovarian Cancer. Clinical Cancer Research. 29(16). 3124–3129. 18 indexed citations
5.
Blanc‐Durand, Félix, Damien Vasseur, Audrey Le Formal, et al.. (2023). Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid. Molecular Cancer. 22(1). 178–178. 4 indexed citations
6.
Blanc‐Durand, Félix, Damien Vasseur, Audrey Le Formal, et al.. (2023). #64 Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid of patient with epithelial ovarian cancer. A32.1–A32. 1 indexed citations
7.
Blanc‐Durand, Félix, Elisa Yaniz‐Galende, Catherine Genestie, et al.. (2022). Immune tumor microenvironnement (iTME) post-neoadjuvant chemotherapy, beyond PD-L1: Novel immune targets in ovarian cancer, data from the CHIVA trial, a GINECO/GINEGEPS study.. Journal of Clinical Oncology. 40(16_suppl). 5554–5554. 1 indexed citations
8.
Auguste, Aurélie, Félix Blanc‐Durand, Marc Deloger, et al.. (2020). Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis. Cells. 9(6). 1496–1496. 31 indexed citations
9.
Blanc‐Durand, Félix, Catherine Genestie, Sébastien Gouy, et al.. (2020). Distribution of novel immune-checkpoint targets in ovarian cancer tumor microenvironment: A dynamic landscape.. Gynecologic Oncology. 160(1). 279–284. 23 indexed citations
10.
Léary, Alexandra, Audrey Le Formal, Sébastien Gouy, et al.. (2020). ctDNA from ascites as an alternative to tumor sampling for HRD (homologous recombination deficiency) testing in ovarian cancer (OC).. Journal of Clinical Oncology. 38(15_suppl). 6066–6066.
11.
Genestie, Catherine, Aurélie Auguste, Soizick Mesnage, et al.. (2020). Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer. Cancers. 12(3). 707–707. 17 indexed citations
12.
Auguste, Aurélie, Catherine Genestie, Marco de Bruyn, et al.. (2018). Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative. Modern Pathology. 31(12). 1851–1861. 40 indexed citations
13.
Auguste, Aurélie, Catherine Genestie, Soizick Mesnage, et al.. (2018). Changes in DNA damage response markers with treatment in advanced ovarian cancer. Gynecologic Oncology. 149. 164–165. 3 indexed citations
14.
Mesnage, Soizick, Aurélie Auguste, Catherine Genestie, et al.. (2016). Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC). Annals of Oncology. 28(3). 651–657. 138 indexed citations
15.
Mesnage, Soizick, Catherine Genestie, Aurélie Auguste, et al.. (2016). Tumor-infiltrating lymphocytes (TILs) and PDL1 expression in ovarian cancer (OC): Evolution with neoadjuvant chemotherapy (NCT) and prognostic value.. Journal of Clinical Oncology. 34(15_suppl). 5512–5512. 1 indexed citations
16.
Léary, Alexandra, Catherine Genestie, Julien Adam, et al.. (2015). Genomic profile and immune infiltrate in paired ovarian cancer (OC) samples pre- and post-neoadjuvant chemotherapy (NC).. Journal of Clinical Oncology. 33(15_suppl). 5575–5575. 1 indexed citations
17.
Albigès, Laurence, Justine Guégan, Audrey Le Formal, et al.. (2014). MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array. Clinical Cancer Research. 20(13). 3411–3421. 134 indexed citations
18.
Albigès, Laurence, Nathalie Auger, Audrey Le Formal, et al.. (2014). CGH array and matching gene expression profiling for identification of distinct molecular variants among type II papillary renal cell carcinomas.. Journal of Clinical Oncology. 32(15_suppl). 4527–4527. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Félix Blanc‐Durand Breakdown of academic impact, for papers by S Liang Breakdown of academic impact, for papers by Joana Sederias Breakdown of academic impact, for papers by Sherri Damare Breakdown of academic impact, for papers by Víctor Rodríguez-Freixinós Breakdown of academic impact, for papers by Ahmed El‐Balat Breakdown of academic impact, for papers by Keizo Tokumo Breakdown of academic impact, for papers by Naoko Komura Breakdown of academic impact, for papers by Anne‐Katrin Zimmermann Breakdown of academic impact, for papers by Linn Woelber
Rankless by CCL
2026